Evidence map›Paper›PMID 28972008›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2017

Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis.

Soumyasri Das Gupta, Misaal Patel, Joseph Wahler, Min Ji Bak, Brian Wall, Mao-Jung Lee, Yong Lin, Weichung Joe Shih, Li Cai, Chung S Yang and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer.Journal of biochemical and molecular toxicology · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Soumyasri Das GuptaDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Misaal PatelDepartment of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Joseph WahlerDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Min Ji BakDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Brian WallDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Mao-Jung LeeDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Yong LinDepartment of Biostatistics, Rutgers School of Public Health, Piscataway, New Jersey.
Weichung Joe ShihDepartment of Biostatistics, Rutgers School of Public Health, Piscataway, New Jersey.
Li CaiDepartment of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Chung S YangDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Nanjoo SuhDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey. nsuh@pharmacy.rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
Prevention of estrogen-mediated mammary carcinogenesis by mixtures of tocopherolsR01AT007036 · NCCIH · RUTGERS, THE STATE UNIV OF N.J. · PI SUH, NANJOO · 2012 to 2016
$1.9M
NCCIH NIH HHS R01 AT007036NIEHS NIH HHS P30 ES005022
6 · The paper itself

Abstract

Despite experimental evidence elucidating the antitumor activities of tocopherols, clinical trials with α-tocopherol (α-T) have failed to demonstrate its beneficial effects in cancer prevention. This study compared the chemopreventive efficacy of individual tocopherols (α-, δ-, and γ-T) and a γ-T-rich tocopherol mixture (γ-TmT) in the August-Copenhagen Irish (ACI) rat model of estrogen-mediated mammary cancer. Female ACI rats receiving 17β-estradiol (E2) implants were administered with 0.2% α-T, δ-T, γ-T, or γ-TmT for 30 weeks. Although α-T had no significant effects on mammary tumor growth in ACI rats, δ-T, γ-T, and γ-TmT reduced mammary tumor volume by 51% (

Indexed as

Gene Expression Regulation, Neoplasticalpha-TocopherolAnimalsAnticarcinogenic AgentsAntineoplastic AgentsAntioxidantsApoptosisCarcinogenesisCell AdhesionCell ProliferationCell Transformation, NeoplasticDisease ProgressionEstrogensExtracellular MatrixFemalegamma-Tocopherolalpha-TocopherolAnticarcinogenic AgentsAntineoplastic AgentsAntioxidantsdelta-tocopherolEstrogensgamma-TocopherolTocopherols

Identifiers

PMID28972008
PMCPMC5826717
OpenAlexW2762007252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.